These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 6123591)

  • 1. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
    Huidobro-Toro JP; Caturay EM; Ling N; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):262-9. PubMed ID: 6123591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between morphine and the opioid-like peptides in the rat vas deferens.
    Huidobro F; Huidobro-Toro JP; Miranda H
    Br J Pharmacol; 1980 Dec; 70(4):519-25. PubMed ID: 6258678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-endorphin. Receptor binding and peripheral opioid activities of [Gln8]-, [Trp27]-, and [Tyr31]-analogs.
    Ho CL; Ko JL; Li CH
    Int J Pept Protein Res; 1988 Jul; 32(1):74-8. PubMed ID: 2851563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-endorphin. Biological activity of analogs containing dermorphin and dynorphin sequences: ileum and vas deferens assays.
    Ho CL; Li CH
    Int J Pept Protein Res; 1987 Jan; 29(1):134-9. PubMed ID: 2883148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
    Sánchez-Blázquez P; Garzón J; Lee NM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):706-11. PubMed ID: 6310079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
    Oka T; Negishi K
    Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 9. Opioid receptor selectivity of dynorphin gene products.
    James IF; Fischli W; Goldstein A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):88-93. PubMed ID: 6141278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the epsilon-type of opioid receptor in the rat vas deferens.
    Garzón J; Schulz R; Herz A
    Mol Pharmacol; 1985 Jul; 28(1):1-9. PubMed ID: 2991732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal release of immunoreactive Met-enkephalin by intraventricular beta-endorphin and its analogs in anesthetized rats.
    Tseng LF; Towell JF; Fujimoto JM
    J Pharmacol Exp Ther; 1986 Apr; 237(1):65-74. PubMed ID: 2420969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors.
    Dean DM; Lemaire S; Livett BG
    J Neurochem; 1982 Mar; 38(3):606-14. PubMed ID: 6276506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat vas deferens: a specific bioassay for endogenous opioid peptides.
    Lemaire S; Magnan J; Regoli D
    Br J Pharmacol; 1978 Nov; 64(3):327-9. PubMed ID: 719230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate activity of peptides derived from the three opioid peptide families on the rat vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM; Höllt V
    Neuropeptides; 1984 Dec; 5(1-3):181-4. PubMed ID: 6099492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of mixed agonist-antagonist properties of [Gln8-Gly31]-beta h-EP-Gly-Gly-NH2 and [Arg9,19,24,28,29]-beta h-EP in the rat vas deferens neuroeffector junction: studies with naloxone, beta-funaltrexamine and ICI 174,864.
    Valenzuela R; Li CH; Huidobro-Toro JP
    J Pharm Pharmacol; 1989 Feb; 41(2):92-6. PubMed ID: 2568435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
    Tseng LF; Cheng SS; Fujimoto JM
    J Pharmacol Exp Ther; 1983 Jan; 224(1):51-4. PubMed ID: 6294283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the opioid receptor in the submucous plexus of the guinea-pig oesophagus.
    Kamikawa Y; Shimo Y
    Br J Pharmacol; 1983 Apr; 78(4):693-9. PubMed ID: 6303485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
    Chang KJ; Blanchard SG; Cuatrecasas P
    Mol Pharmacol; 1984 Nov; 26(3):484-8. PubMed ID: 6149459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
    Schulz R; Wüster M; Herz A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.